CAU.AU · Cronos Australia Limited

-

Please sign in to comment on CAU.AU

1 Comment

Admin

4 years, 1 month ago

Cronos Australia Limited is currently in a long term downtrend where the price is trading 7.0% below its 200 day moving average.

From a valuation standpoint, the stock is 56.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 111.1.

Its net income has dropped by 8.0% to $-2M since the same quarter in the previous year.

Finally, its free cash flow grew by 15.9% to $-1M since the same quarter in the previous year.

Based on the above factors, Cronos Australia Limited gets an overall score of 2/5.

Industry	Pharmaceuticals
Exchange	AU
CurrencyCode	AUD
ISIN	AU0000060691
Sector	Healthcare

Market Cap	301M
PE Ratio	54.0
Target Price	1
Dividend Yield	1.7%
Beta	0.07

ABOUT

Cronos Australia Limited

Cronos Australia Limited engages in the sale and distribution of medicinal cannabis products, and operation of medicinal cannabis clinic businesses in Australia and Asia. It operates through three segments: Medical, Clinics, and Consumer. The company sells its medicinal cannabis products under the Adaya brand, as well as through online marketplace platform. It also offers hemp seed oil personal care consumer products under the Bathing Shed brand; and CBD-based products under the FCTR and Saiph brands. The company was incorporated in 2018 and is based in South Yarra, Australia.

CAU.AU · Cronos Australia Limited

-

Cronos Australia Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Cronos Australia Limited using a moving average strategy